Search

Viatris Inc

Закрыт

СекторЗдравоохранение

16.88 -0.24

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

16.86

Макс.

16.97

Ключевые показатели

By Trading Economics

Доход

-295M

-119M

Продажи

240M

3.8B

Прибыль на акцию

0.69

Дивидендная доходность

2.94

Рентабельность продаж

-3.162

Сотрудники

30,000

EBITDA

9.4M

653M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+14.93% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

2.94%

2.18%

Следующий отчет о доходах

5 нояб. 2026 г.

Дата следующей выплаты дивидендов

16 сент. 2026 г.

Следующая эксдивидендная дата

23 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.6B

19B

Предыдущая цена открытия

17.12

Предыдущая цена закрытия

16.88

Новостные настроения

By Acuity

50%

50%

131 / 339 Рейтинг в Healthcare

Viatris Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 сент. 2026 г., 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 сент. 2026 г., 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 сент. 2026 г., 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 сент. 2026 г., 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 авг. 2026 г., 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 авг. 2026 г., 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 авг. 2026 г., 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 авг. 2026 г., 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 авг. 2026 г., 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 авг. 2026 г., 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 авг. 2026 г., 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 авг. 2026 г., 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 авг. 2026 г., 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 авг. 2026 г., 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 авг. 2026 г., 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 авг. 2026 г., 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 авг. 2026 г., 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 авг. 2026 г., 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 авг. 2026 г., 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 авг. 2026 г., 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 авг. 2026 г., 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6 авг. 2026 г., 23:01 UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5 авг. 2026 г., 23:11 UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4 авг. 2026 г., 23:06 UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3 авг. 2026 г., 20:06 UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31 июл. 2026 г., 21:02 UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

30 июл. 2026 г., 18:56 UTC

Event

Viatris shares are trading lower despite FDA approval of the Gwyn Lo contraceptive patch. Broader economic data may be impacting the stock's performance.

29 июл. 2026 г., 22:03 UTC

Event

Viatris Inc. shares are lower in after-market hours despite FDA approval of the Gwyn Lo contraceptive patch, amid broader market caution over geopolitical tensions.

28 июл. 2026 г., 19:36 UTC

Social Media

Viatris shares are higher today, supported by strong sector gains and a significant rise in January 2027 $10 call options activity.

27 июл. 2026 г., 19:11 UTC

Viatris Inc shares are higher today, breaking a trend of daily gains. No specific news was identified to explain this movement.

Сравнение c конкурентами

Изменение цены

Viatris Inc Прогноз

Целевая цена

By TipRanks

14.93% рост

Прогноз на 12 месяцев

Средняя 19.4 USD  14.93%

Максимум 23 USD

Минимум 14 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для Viatris Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

5 ratings

2

Покупка

2

Удержание

1

Продажа

Настроения

By Acuity

131 / 339Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat